Prior research has found that adults with T1D and obesity who participated in a BLI for adults with diabetes demonstrated significantly reduced body weight, HbA1C, and total insulin doses prescribed compared to a matched usual care control group [37]. This evidence concerns the gene INS and type 1 diabetes mellitus.